for Jan 30, 2023
Just out in @CIDJournal: Further evidence of the interplay between host immune status and variant in development of one of the most dreaded long covid symptoms -- prolonged severe fatigue. Vaccination associated with reduced risk. https://t.co/udroO6c4Qt pic.twitter.com/A6ktggmgpW
— Paul Sax (@PaulSaxMD) January 30, 2023
I’m pleased the editors of the journal BMC Infectious Diseases added an Editor’s Note to this dreadful paper, written & funded by well known anti-vaccine activists. I’m pleased they’re investigating how this screw-up happened
— Prof Gavin Yamey MD MPH (@GYamey) January 30, 2023
It should be retracted asaphttps://t.co/CMzb4xYv6i
New research: Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trialhttps://t.co/RYiB60Q40Q pic.twitter.com/sR6IEncrV5
— The Lancet Infectious Diseases (@TheLancetInfDis) January 30, 2023
Antibiotic #stewardship programs should consider targeting social determinants of health along with underlying health conditions of patients being treated with antibiotics➡️does poverty ⬆️ abx prescribing rates through underlying health conditions?
— ASHE Journal (@ASHE_Journal) January 30, 2023
https://t.co/7L7Na8b0wl
BMC Infectious Diseases Journal published a paper by Prof Mark Skidmore an economist at Michigan State University.
— David Atherton (@DaveAtherton20) January 30, 2023
In it he claims 280,000 people have died of the covid vaccine. https://t.co/jQhWycpCO2
🆕️⚡️⚡️systematic review & meta-regression analysis
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 30, 2023
Incidence of infection with MDR Gram-negative bacteria & VRE in carriers
The pooled cumulative incidence of infection was 14% at a median follow-up time of 30d for MDR-GNB & 8% at 30d for VRE #IDTwitterhttps://t.co/3ygIxB6pZC
Read our February issue! Featuring BA.5 infections in Denmark, RCT to reduce antibiotic use in hospital, and influenza in vaccinated people in Latin Americahttps://t.co/3p8ZzgLYCY pic.twitter.com/oZ2qvgVfdl
— The Lancet Infectious Diseases (@TheLancetInfDis) January 30, 2023
🆕️⚡️@ASHE_Journal @SHEA_Epi
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 30, 2023
Impact of phenotypic rapid diagnostic assay *Accelerate PhenoTest * with (AMS) on duration of empiric antibiotics for gram-negative bacteremia
Duration of empiric antibiotics decreased in RDT+AMS (4d vs 2 d) more👇 #IDTwitter https://t.co/XHY6fQd3xl pic.twitter.com/sGI1wNxkGx
Marburg virus vaccine shows promising results in first-in-human study. This 1st-in-human Phase 1 study tested an experimental vaccine candidate, known as cAd3-Marburg. The vax was developed at Nat'l Institute of Allergy and Infectious Diseases https://t.co/iK2UiuUH1u
— delthia ricks 🔬 (@DelthiaRicks) January 30, 2023
Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to ATS/IDSA Treatment Guidelines | Clinical Infectious Diseases | Oxford Academic https://t.co/HoNDxssKFA
— Ruda Mohaweche, MD, MBA (@rudmoha) January 30, 2023
Why do bacteria become resistant to antibiotics? New video added to https://t.co/2LDLOQ5jWk https://t.co/vzizDdjqkV
— Antibiotic Prescribing (@AntibioticPresc) January 30, 2023
📢 This Wednesday IIOP and HSE AMRIC are collaborating to host a parallel session on the topic of 'Empowering all pharmacists to deliver antimicrobial stewardship' as part of @RCSI_Irl 2023 Charter Meeting.
— IIoP (@IIOPharmacy) January 30, 2023
Register to attend this session at: https://t.co/UfGjwaUU07 pic.twitter.com/8kyF2wfK94
New in @ICHEJournal:
— Infection Control & Hospital Epidemiology (@ICHEJournal) January 30, 2023
Authors performed a point-prevalence study of antimicrobial use at pediatric postacute and long-term care (pPALTC) settings
5-7% residents w/ antimicrobials for:
➡️41% infectious
➡️24% non-infx
➡️24% prophylaxis
➡️11% unknown
📄 https://t.co/jeXIgIZC9a pic.twitter.com/8wYxRc80xE
Covid-19 deaths displace influenza and pneumonia, becoming the top cause of death caused by any infectious or respiratory disease in children.
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 30, 2023
It caused “substantially” more deaths than any vaccine-preventable disease historically #IDTwitter #COVID19 https://t.co/6724R6iz0O
The tweet mentions boosters. In Finland, many are not even allowed to get boosted. A corona infection is regarded as a vaccine dose. As a 42-year-old who has had covid once, I'm entitled only to the basic vaccination series of two shots.https://t.co/ZlRvLYMLo7 pic.twitter.com/mQHXeumI84
— Virpi Flyg ┃ @virpiflyg@mas.to (@VirpiFlyg) January 30, 2023
Large multiplex PCR panels were associated with lower 30-day acute gastroenteritis-related follow-up cost and risk of hospitalization, and increased diagnostic yield compared to traditional work-up, according to this #JClinMicro study: https://t.co/rxIcUvi6ld pic.twitter.com/zGoOCo6PWF
— ASM (@ASMicrobiology) January 30, 2023
🌎 New read of the week!@natalievestin highlights the "Histoplasmosis Porto Alegre Manifesto," which calls for improved access to antigen tests and liposomal AmB across endemic areas of Latin America @PLOSNTDs @PasqualottoAlehttps://t.co/RdPBizrVpL
— CIDRAP-ASP (@CIDRAP_ASP) January 30, 2023
Did you know that ISAC has a YouTube channel?
— ISAC (@ischemo) January 30, 2023
Subscribe to be the first to get access to on-demand recordings of all our educational webinars on topical issues related to #infectiousdiseases / #antimicrobialresistance.https://t.co/RT4nGhZ29K pic.twitter.com/DRGGKRcd1b
#IDTwitter @ASHE_Journal Rapid phenotypic diagnostic assays on GNR bacteremia impacts antimicrobial stewardship! https://t.co/GMnhdXu44l
— Gonzalo Bearman (@gonzalobearman) January 30, 2023
New in @TheLancetInfDis>
— The Lancet Microbe (@LancetMicrobe) January 30, 2023
Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with #COVID19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trialhttps://t.co/Pkw9Bo2biH #AMR
Save the date! The 7th edition of the #AMRConference will be held in Basel from 16-17 March. Register here: https://t.co/2TwGzkOuNp
— BEAM Alliance (@AllianceBEAM) January 30, 2023
Check out our programme online, which provides a 360° view of the #AMR #innovation panorama.
Come & join the live discussion!#infectiousdiseases pic.twitter.com/0wCIi2TWCH
New Job! Band 7 Pharmacist Infectious Diseases & COVID Service. Advance your specialist knowledge in the evolving field of ID! Be at the forefront of tackling antimicrobial resistance🦠🚨! Join a supportive and inclusive MDT! Closes 12th Feb https://t.co/IBxMEcl2Bv
— GSTT_Pharmacy (@GSTT_Pharmacy) January 30, 2023
#Marburg vaccine shows promising results in 1st-in-human study
— MicrobesInfect (@MicrobesInfect) January 30, 2023
Phase 1 study tested a MARV vaccine candidate (cAd3-Marburg) that uses modified chimpanzee adenovirus (cAd3) that can no longer replicate or infect cells & displays a MARV surface glycoproteinhttps://t.co/cLKYKMInAV
If you're a student, or recent graduate, and want a great summer research experience in Infectious Diseases, please apply! Deadline is deadline is Friday, February 24 2023. @bwh_id https://t.co/5IeHrgloGo pic.twitter.com/M3nqwG2fwd
— Paul Sax (@PaulSaxMD) January 30, 2023
“Among patients hospitalised with COVID-19 pneumonia, rationalising antibiotic therapy with antimicrobial stewardship prospective audit and feedback interventions did not negatively affect patient outcomes despite an overall reduction in antibiotic use” https://t.co/SEr9ihuHoF
— Amesh Adalja (@AmeshAA) January 30, 2023
Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial https://t.co/urYKU2zYxS
— Laura Piddock 💙 (@LauraPiddock) January 30, 2023
So here's my issue: What is the point of antibiotics/antimicrobial stewardship if pharmacists are just going to hand out antibiotics as they see fit for conditions they are not trained to treat?
— TRexMD (@TRexMD780) January 30, 2023
Am I angry for no reason or was this overreach by that pharmacist?
Medical schools are trying to do both (intelectual rigor and diversity) not one or the other as this opinion piece in @WSJ suggests. https://t.co/B3sd41ufub
— Carlos del Rio (@CarlosdelRio7) January 30, 2023
For persons "aged 0 to 19 years in the US, C19 ranked 8th among all causes of deaths, 5th in disease-related causes of deaths..& 1st in deaths caused by infectious or respiratory diseases. C19 deaths constituted 2% of all causes of death in this age group"https://t.co/CasMreyeVP
— Mirella Sarah, PhD 🔎😷 (@Mirella_PhD) January 30, 2023
New from authors @RWJUH: Impact of phenotypic rapid diagnostic assay on duration of empiric antibiotics for gram-negative bacteremia https://t.co/ZliOJND4kh
— ASHE Journal (@ASHE_Journal) January 30, 2023
The role of social circle COVID-19 illness and vaccination experiences in COVID-19 vaccination decisions: an online survey of the United States population | BMC Infectious Diseases | Full Text https://t.co/FJE4X5I32g
— Dr David Cartland (@CartlandDavid) January 30, 2023
As California’s climate heats up, there has been a large increase in the number of cases of infection with the soil-borne fungal pathogen, #Coccidioides, especially on the Central Coast.#coccidioidomycosis #ValleyFeverhttps://t.co/ABfER7QNB3
— MicrobesInfect (@MicrobesInfect) January 30, 2023
Japanese study shows that #measles virus that persists in the body can develop mutations in the F protein, which controls how the virus infects cells.
— MicrobesInfect (@MicrobesInfect) January 30, 2023
The mutated protein can interact with its normal form, making it capable of infecting the brain.https://t.co/FcakXOSBhj
MBP scientists & educators! Level up your CRISPR game or help students succeed in MBP w/ these new titles from #ASMPress & @wileymicrobio: CRISPR: Biology and Applications, Molecular Biotechnology 6e, and Molecular Genetics of Bacteria 5e. Get them now at https://t.co/7FHUpcVy1o pic.twitter.com/Ift375hHAk
— ASM (@ASMicrobiology) January 30, 2023
Worth preventing. “…for the study period [Aug ‘21-July ‘22] Among children & young people…0-19 yrs in the US, CoV-19 ranked 8th among all causes of death; 5th among all disease-related causes…& 1st in deaths caused by infectious or respiratory diseases. https://t.co/V3VwpSl6Hy
— Jeffrey Duchin, MD @DocJD@mastodon.world (@DocJeffD) January 30, 2023
Neglected tropical diseases (#NTDs) are a group of twenty parasitic, viral, and bacterial infectious diseases impacting more than 1.7B people, yet rarely seen in high-income countries. This #WorldNTDDay, join us in helping to eradicate them. https://t.co/DFjuBQNDvo
— Helmsley Charitable Trust (@HelmsleyTrust) January 30, 2023
New study from @flaxter and colleagues finds that COVID-19 was the 8th-leading cause of death for kids from August 2021-July 2022, as well as the leading cause of death among infectious/respiratory diseases. COVID continues to present a significant burden.https://t.co/BcrVYWrnBZ
— Benjy Renton (@bhrenton) January 30, 2023
The average temperature of the human body has been steadily declining since the middle of the 19th century, & scientists weren't sure why.
— MicrobesInfect (@MicrobesInfect) January 30, 2023
A new study suggests that gut microbes may play a role.https://t.co/haZ8TPCj5o #microbiota
#MicrobiologyMonday: New research in #mSphere shows how Trypanosoma cruzi, the parasite that causes Chagas disease, undergoes immunologically “silent” proliferation, even in the presence of a strong immune T cell memory generated by previous infection. https://t.co/icSV0R3Urj pic.twitter.com/ryNJRyIFr4
— ASM (@ASMicrobiology) January 30, 2023
Is penicillin allergy de-labelling about to find its place in UK antimicrobial stewardship strategy? https://t.co/0jGemByD7J
— Truthoverdishonesty (@Nigelj08223326) January 30, 2023
penicillin allergy records, increased length of hospitalisation, higher rates of ICU admission and hospital readmission@reesprescribe @AdrianKennedy
📢Special Issue "#Antimicrobial Use, Resistance and #Stewardship, 2nd Volume" is Looking forward to Your Submission！
— Antibiotics MDPI (@antibioticsmdpi) January 30, 2023
✏️Guest Edited Dr. Mamoon Aldeyab @aldeyab
👉https://t.co/EYokERCDSS pic.twitter.com/kjhSNLaWld
Epidemiological, Clinical and Household Transmission Characteristics of Children and Adolescents Infected with SARS-CoV-2 Omicron Variant in Shanghai, China: a Retrospective Multicenter Observational Study - International Journal of Infectious Diseases https://t.co/plrwVdqIoh
— Prof. Dr. Sanjeev Bagai (@BagaiDr) January 30, 2023
#DYK: About 1️⃣ in 5️⃣ people in the US who get #measles will be hospitalized? #GetVaccinated to help #PreventMeasles.
— NFID (@NFIDVaccines) January 30, 2023
Learn more at https://t.co/YKmG6qB5Tj pic.twitter.com/ccQPvFz0P3
More than 160 organizations have heralded the #PASTEUR Act as a critical tool to address #antibiotic resistance. @IDSAInfo President @CarlosdelRio7 explains how: https://t.co/4nT8iO5W6D
— Save Antibiotics (@saveantibiotics) January 30, 2023
Studies: COVID vaccine boosters lower risk of death in adults, ED visits in kids#COVID19 boosters lower the risk of death among adults >90% and increase protection against severe disease in kids 5 to 11 years by 77%, new data revealhttps://t.co/d0gQFADOdZ
— CIDRAP (@CIDRAP) January 30, 2023
#IDTwitter @ASHE_Journal Poverty is a social determinant of health and likely impacts antimicrobial prescribing rates, a novel ecological study, only in ASHE... https://t.co/8EhrBtJVdW
— Gonzalo Bearman (@gonzalobearman) January 30, 2023
We’re excited to announce a new research project at @ImperialNHS exploring infectious diseases and links to pregnancy. Supported by the Parasol Foundation, the study will help female scientists work towards better care and treatment for women.
— Imperial Health Charity 💙 (@ImperialCharity) January 30, 2023
Read more: https://t.co/1avnz5rNrD pic.twitter.com/884OlENCKW
And the linked comment: Too many antibiotics for patients with COVID-19 despite low bacterial infectionshttps://t.co/FfIcsZfx9r
— The Lancet Infectious Diseases (@TheLancetInfDis) January 30, 2023
Myth: Sharing knowledge and collaborating diminished my power and recognition.
— Dena van den Bergh (@inspired2leadQH) January 30, 2023
This week I spoke with my friend and collaborator Dr Esmita Charani, a global leader in Antimicrobial Stewardship working across the UK, South Africa, India, Norway and many…https://t.co/XC0gMnhXba
AI continues to gain momentum in the biopharmaceutical industry in 2023 - https://t.co/Vopw7xWPFG - #POLB #PoolbegPharma #ClinicalStage #NovelTreatments #InfectiousDiseases #Immunotherapy #AI #DrugDiscovery #Investing
— DirectorsTalk (@DirectorsTalk) January 30, 2023
Seminar | Dr Deborah Hoyle
— Edinburgh Infectious Diseases (@edin_EID) January 30, 2023
The first @EdiAMR seminar of the year is by Deborah Hoyle from @roslininstitute in the role of plasmids, integrons and metal resistance genes in #AMR carriage by livestock.
Joining info ➡️https://t.co/6oAGYc464Q pic.twitter.com/7cK6rPfR9w
Thanks @sprague & @NEOdotLIFE for sharing his experience with our #COVID19 #research study. Nearly 3 yrs after the virus hit the US, we continue to study antibodies & individual epitope repertoires for COVID-19 + other infectious diseases. https://t.co/3fe2CMj7RZ #immuneresponse
— Serimmune (@serimmune) January 30, 2023
This a a favorite of mine:
— Janet (@Bradley22Janet) January 30, 2023
"The health ministry's infectious diseases chief Daniel Koch said scientists had concluded that young children did not transmit the virus."https://t.co/xrq7MaqU90
Studies estimate COVID and all-cause deaths in youth, pregnancy
— CIDRAP (@CIDRAP) January 30, 2023
Among children, #COVID19 was the eighth-leading cause of death from any cause and first in deaths caused by infectious or respiratory diseasehttps://t.co/XpW3z9x7Bd
Photo: G Witteveen / Flickr cc
Professor Holmes said the fact the Chinese population was so susceptible to COVID-19 — due to lack of prior immunity — meant the virus wasn't under pressure to mutate. https://t.co/o8niWRaekY
— Peter Collignon (@CollignonPeter) January 30, 2023
Trial data support antibiotic audit and feedback in COVID patients https://t.co/IU8DBsn3A6
— Crawford Kilian (@Crof) January 30, 2023
⚡️The NIH Panel now recommends against the use of Evusheld "tixagevimab +cilgavimab" as PrEP of #COVID19 ⚡️
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 30, 2023
Currently, there is no authorized or approved agent for use as PrEP of COVID-19, take 👇precautions as per CDC#IDTwitter https://t.co/GkDZBaduKL pic.twitter.com/ccLQH7uIKO
#Malaria induced innate immune modulation of an atypical cellular population plays a substantial role in driving and maintaining immunity against malaria, a new study from scientists at @Stanford has demonstrated. Learn more: https://t.co/fwqwLQGRoa pic.twitter.com/llCO4EAJZD
— Genetic Engineering & Biotechnology News (@GENbio) January 30, 2023
In recognition of #WorldNTDDay2023, we are sharing the #ATMI22 best practices for improving access to effective treatment for #NTDs & other infectious diseases in #LMICs 👉 https://t.co/KodEkixORx#BeatNTDs #access2meds #pharma #globalhealth pic.twitter.com/dxDXbcxn3q
— Access to Medicine Foundation (@AtMIndex) January 30, 2023
Malaria-induced innate immune modulation of an atypical cell-type plays a substantial role in driving and maintaining #immunity against #malaria in #Ugandan children, reports a study from Prasanna Jagannathan’s @prasannaj77 team @Stanford University. https://t.co/0PqT6FAuv0
— Anjali A. Sarkar (@Anjali_Sarkar) January 30, 2023
continuing puzzle of defining duration of SARS-CoV-2 infectivity | The Journal of Infectious Diseases | Oxford Academic https://t.co/MOE9nb6lGw
— Ares (@ares982) January 30, 2023
The slight increases in COVID-19 positivity rate should not be a cause of concern now as the hospital admissions for severe and critical cases remain low, infectious diseases expert Dr. Rontgene Solante said Monday.https://t.co/357ngJbxHK
— GMA News (@gmanews) January 30, 2023
Do you used #PCT to help with diagnostics?🔍 Procalcitonin is biomarker used for diagnosing #infections and sepsis. Learn about its benefits, limitations and impacts on #AMS in this 3-week CPD-accredited course. Sign up 🖊️https://t.co/weswa4WjM3 #ProcalcitoninAMS pic.twitter.com/w0rb2FXJep
— BSAC (@BSACandJAC) January 30, 2023
On the #NETEC #SituationReport for Jan. 30, 2023, @harrisgmd, a NETEC expert and infectious diseases & critical care physician at @EmoryUniversity, shares 3 things you should know about Highly Pathogenic Avian Influenza A(H5N1): https://t.co/B19TjgzMoB#HPAI #H5N1 #BirdFlu pic.twitter.com/9AmD39iRP0
— NETEC (@TheNETEC) January 30, 2023
Positive news in the #AntimicrobialResistance field: better understanding of this toxin's mechanism of action, paving the way for potential new antibiotics down the line
— Dr. Alicia (@aliciad3) January 30, 2023
Molecular mechanism of topoisomerase poisoning by the peptide antibiotic albicidinhttps://t.co/y0CwK4BqAW
Trial data support antibiotic audit and feedback in COVID patients
— CIDRAP (@CIDRAP) January 30, 2023
A randomized trial in Canada finds that #COVID19 patients in the audit and feedback group had lower antibiotic use but similar outcomes to patients treated with standard of carehttps://t.co/SOuGmbALKt pic.twitter.com/bjwXR1SCfG
“If you look at infectious diseases in children in the U.S. historically, in the period before vaccines became available, hepatitis A, rotavirus, rubella and measles were all major causes of death.”https://t.co/DhxBK0vQzz
— The Washington Times (@WashTimes) January 30, 2023
Current COVID-19 vaccines provide protection against severe disease and death, but we need better research and better vaccines to protect against the transmission of the disease, says IDSA President @CarlosdelRio7.
— IDSA (@IDSAInfo) January 30, 2023
Watch the full press briefing: https://t.co/t6SWiUG0DB pic.twitter.com/ODGTsNxZh6
Hey look who is promoting #SHEASpring2023!! @DGlaucomflecken makes a great case why you should attend!!
— Mike Stevens (@Dr_Mike_Stevens) January 30, 2023
How cool do ID docs, pharmacists and epidemiologists feel right now? 😎📊💊🦠https://t.co/Lca6ahrEt6 @SHEA_Epi
'Global Infectious Diseases in December 2022: Monthly Analysis' an article on #ScienceOpen: https://t.co/Up8hWpp4Xq
— haibao.xue (@XueHaibao) January 30, 2023
The joint BSAC and @gardp_amr
— BSAC (@BSACandJAC) January 30, 2023
virtual ACC2023 conference in collaboration with @AfricaCDC and @ReActAfrica_RAN is taking place THIS WEEK!
View the programme and book your FREE place here: https://t.co/zRpVoFrpiV pic.twitter.com/2KjZonqzrL
Zang et al. found that the resazurin microplate method was effective in detecting vancomycin resistance in E. faecium & linezolid resistance in E. faecalis, so it could be used for the rapid screening of these pathogens in clinical practice:https://t.co/onXeFwNQ7n#JACNews
— BSAC (@BSACandJAC) January 30, 2023
📣 Calling all #Educators - Want to learn how to talk to young people about #Infection and the importance of #Antibiotics? 🦠💊 Sign up to the #BSACeBug course from @eBug_UK & @UKHSA today! https://t.co/E1iUaVvL4y pic.twitter.com/qYZFdnGZVM
— BSAC (@BSACandJAC) January 30, 2023
Report highlights the occurrence of beta-lactamase resistance genes in US hospitalshttps://t.co/yO4YXCzGYQ
— CIDRAP (@CIDRAP) January 30, 2023
A 5-year study of US hospital data illustrates trends in E coli and Klebsiella pneumoniae isolates carrying beta-lactamase antibiotic resistance genes#AMR
Created by Cameron Forbes. Last updated January 31, 2023 at 05:16 EST.